Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Схожие документы

• Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
  по: Xu, S, и др.
  Опубликовано: (2021)
• Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
  по: Wamil, M, и др.
  Опубликовано: (2020)
• Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
  по: Leal, J, и др.
  Опубликовано: (2022)
• Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
  по: Holman, R, и др.
  Опубликовано: (2017)
• Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
  по: Currie, G, и др.
  Опубликовано: (2017)